Figure 4
Variance in clinical outcomes explained by different models. Predictive utility of the R-map calculated in each target (left) and an agreement map, in which only regions predictive for both targets were retained (right). Using the the R-map calculated on either target alone, a significant portion of variance in outcomes in both cohorts could be explained (R = 0.27 at P < 0.001 for STN; R = 0.32 at P = 0.042 for GPi). The agreement map was able to explain additional variance in each of the two cohorts (R = 0.34 at P < 0.001 for STN; R = 0.39 at P = 0.022). Single target maps on the left correspond to renderings in Fig. 3 and are shown as volumetric cuts at z = −50, −30, −10, 10, 30 and 50 mm. The agreement map is shown both in volumetric and surface fashion. The BigBrain atlas served as the backdrop for volumetric representations.25

Variance in clinical outcomes explained by different models. Predictive utility of the R-map calculated in each target (left) and an agreement map, in which only regions predictive for both targets were retained (right). Using the the R-map calculated on either target alone, a significant portion of variance in outcomes in both cohorts could be explained (R = 0.27 at P < 0.001 for STN; R = 0.32 at P = 0.042 for GPi). The agreement map was able to explain additional variance in each of the two cohorts (R = 0.34 at P < 0.001 for STN; R = 0.39 at P = 0.022). Single target maps on the left correspond to renderings in Fig. 3 and are shown as volumetric cuts at z = 50, 30, 10, 10, 30 and 50 mm. The agreement map is shown both in volumetric and surface fashion. The BigBrain atlas served as the backdrop for volumetric representations.25

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close